Dipyridamole Tablet, Film Coated
Product Images NDC 68382-187
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Dipyridamole (NDC 68382-187). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
0d6e24a6 46a9 4797 A64f 1b5fd622a633 02
Dipyridamole Tablets, USP, containing 25 mg of dipyridamole per tablet, are available in a package of 500 tablets only on prescription. The label advises to store the tablets between 20°C and 25°C, to dispense them in a tight light-resistant container, and to keep them out of children's reach. Usual dosage and prescribing information can be found in the package insert provided by the distributor Zydus Pharmaceuticals.*
0d6e24a6 46a9 4797 A64f 1b5fd622a633 03
Dipyridamole is a medication in tablet form that is only available with a prescription. Each tablet contains 50 mg of Dipyridamole, USP. The usual dosage must be checked in the package insert prior to use. It should be stored in temperatures between 20°C to 25°C (68°F to 77°F). It is recommended to dispense it in a light-resistant container, and keep it out of reach of children. Additional information is available on the package insert at zydususa.com/products, or by calling 1-877-993-6779. This medication is distributed by Zydus Pharmaceuticals (USA) Inc. in Pennington, NJ 08534, and created by Cadila Healthcare Ltd in Ahmedabad, India.*
0d6e24a6 46a9 4797 A64f 1b5fd622a633 04
This is a description of a medication with the active ingredient dipyridamole. Each tablet contains 75mg of dipyridamole. The recommended dosage and complete prescribing information can be found in the package insert. The tablets should be stored at room temperature in a controlled environment and dispensed in a light-resistant container. The medication is manufactured by Cadla Heathcare Ltd in Ahmedabad, India, and distributed in the United States by Zydus Pharmaceuticals. The product should be kept away from children. Contact information for obtaining the package insert is provided.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.